2021
DOI: 10.3389/fcimb.2021.650163
|View full text |Cite
|
Sign up to set email alerts
|

Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting

Abstract: BackgroundThe prompt diagnosis of pulmonary tuberculosis (PTB) remains a challenge in clinical practice. The present study aimed to optimize an algorithm for rapid diagnosis of PTB in a real-world setting.Methods28,171 adult inpatients suspected of having PTB in China were retrospectively analyzed. Bronchoalveolar lavage fluid (BALF) and/or sputum were used for acid-fast bacilli (AFB) smear, Xpert MTB/RIF (Xpert), and culture. A positive mycobacterial culture was used as the reference standard. Peripheral bloo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 18 publications
1
3
0
Order By: Relevance
“…Therefore, the combination of these two indicators could mainly contribute to improving the specificity, not the sensitivity. Second, we found that the sensitivity of TBAg/PHA ratio on distinguishing ATB from LTBI in this study was obviously lower than those reported in several previous studies ( 22 ), while similar with the utility obtained in a recent real-world data analysis from China ( 38 ) and another study from Japan ( 39 ). It was observed that the studies with good performance were often performed with patient exclusion such as immunosuppression.…”
Section: Discussionsupporting
confidence: 87%
“…Therefore, the combination of these two indicators could mainly contribute to improving the specificity, not the sensitivity. Second, we found that the sensitivity of TBAg/PHA ratio on distinguishing ATB from LTBI in this study was obviously lower than those reported in several previous studies ( 22 ), while similar with the utility obtained in a recent real-world data analysis from China ( 38 ) and another study from Japan ( 39 ). It was observed that the studies with good performance were often performed with patient exclusion such as immunosuppression.…”
Section: Discussionsupporting
confidence: 87%
“…Non-tuberculous mycobacteria (NTM) refer generally to mycobacteria other than Mycobacterium tuberculosis complex (MTB) and Mycobacterium leprae. Moreover, MTB and NTM infections often cause indistinguishable clinical symptoms, but their treatment can be vastly different (Peng et al, 2021 ). Clinically, the low prevalence of NTM infections puts them rarely in the differential diagnosis of CNS infections, which occurs more frequently in patients with immunosuppression.…”
Section: Discussionmentioning
confidence: 99%
“…To some extent, these screening tests may hinder the early diagnosis and treatment of PTB. 19 PCR is a technique that amplifies DNA and RNA in vitro through DNA replication. 20 PCR assays for M. tb detection have the following advantages: 1) bacteria at a concentration lower than the detectable levels of regular screening tests can be identified after DNA or RNA amplification, which is beneficial to the early diagnosis of PTB 21 ; 2) PCR assays are more sensitive to PTB without cavitation compared with traditional approaches; 3) in addition to viable bacteria, dead bacteria without DNA degradation can also be amplified to identify lesions in the lungs and prevent missed or erroneous diagnosis; 22 4) PCR reagents work in parallel with anti-TB drugs to examine whether M. tb DNA has been completely degraded through quantitative determination.…”
Section: Discussionmentioning
confidence: 99%